Literature DB >> 6514306

The treatment of myopia with atropine and bifocals. A long-term prospective study.

R S Brodstein, D E Brodstein, R J Olson, S C Hunt, R R Williams.   

Abstract

Two hundred fifty-three patients were followed for up to nine years (mean, 4 1/4 years). They were on a regimen of atropine 1% once a day in an attempt to retard myopic progression. Their rate of myopic progression prior to atropine treatment was compared with 146 controls. The rates of myopic progression during and after treatment were also compared to those of the controls. The results from several analyses showed a marked flattening in the rate of myopic progression during treatment, and the rate of myopic progression after treatment ran parallel to those in the control group. Age in relation to myopic progression was evaluated in subgroups. A variation existed in the rate of myopic progression in the controls. The fastest rate of myopic progression occurred between eight and 12 years of age, and the slowest rate of myopic progression developed in those patients over 18 years of age.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6514306     DOI: 10.1016/s0161-6420(84)34138-0

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  22 in total

Review 1.  Interventions to slow progression of myopia in children.

Authors:  Jeffrey J Walline; Kristina Lindsley; Satyanarayana S Vedula; Susan A Cotter; Donald O Mutti; J Daniel Twelker
Journal:  Cochrane Database Syst Rev       Date:  2011-12-07

Review 2.  Aetiology of myopia.

Authors:  C I Phillips
Journal:  Br J Ophthalmol       Date:  1990-01       Impact factor: 4.638

3.  Presentation of TRPM1-Associated Congenital Stationary Night Blindness in Children.

Authors:  Virginia Miraldi Utz; Wanda Pfeifer; Susannah Q Longmuir; Richard John Olson; Kai Wang; Arlene V Drack
Journal:  JAMA Ophthalmol       Date:  2018-04-01       Impact factor: 7.389

Review 4.  Efficacy and Adverse Effects of Atropine in Childhood Myopia: A Meta-analysis.

Authors:  Qianwen Gong; Miroslaw Janowski; Mi Luo; Hong Wei; Bingjie Chen; Guoyuan Yang; Longqian Liu
Journal:  JAMA Ophthalmol       Date:  2017-06-01       Impact factor: 7.389

5.  Progression of myopia.

Authors:  R H Kennedy
Journal:  Trans Am Ophthalmol Soc       Date:  1995

6.  Pharmaceutical intervention for myopia control.

Authors:  Prema Ganesan; Christine F Wildsoet
Journal:  Expert Rev Ophthalmol       Date:  2010-12-01

7.  The effect on refractive error of unilateral atropine as compared with patching for the treatment of amblyopia.

Authors:  Michael X Repka; Michele Melia; Maya Eibschitz-Tsimhoni; Richard London; Elbert Magoon
Journal:  J AAPOS       Date:  2007-06       Impact factor: 1.220

Review 8.  Myopia onset and progression: can it be prevented?

Authors:  Andrea Russo; Francesco Semeraro; Mario R Romano; Rodolfo Mastropasqua; Roberto Dell'Omo; Ciro Costagliola
Journal:  Int Ophthalmol       Date:  2013-09-17       Impact factor: 2.031

Review 9.  Pharmacology of myopia and potential role for intrinsic retinal circadian rhythms.

Authors:  Richard A Stone; Machelle T Pardue; P Michael Iuvone; Tejvir S Khurana
Journal:  Exp Eye Res       Date:  2013-01-08       Impact factor: 3.467

10.  Accommodation and induced myopia in marmosets.

Authors:  David Troilo; Nicole Quinn; Kayla Baker
Journal:  Vision Res       Date:  2007-03-13       Impact factor: 1.886

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.